glp-1 drug least chemical modification

glp-1 drug least chemical modification GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation PDB-101: Diabetes Mellitus: Diabetes Mellitus:

Name: glp-1 drug least chemical modification GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation PDB-101: Diabetes Mellitus: Diabetes Mellitus:
Brand: www.rasophiles.fr
SKU: 18791650539
Price: 23.46 USD
Availability: InStock
Rating: 4.7308 (25 reviews)

SKU: 18791650539

4.7

EUR23.46 EUR56.46

Pay in 4 interest-free payments of $5.87 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 30 - Sep 4

Description

In a unilateral ureteral obstruction-induced model of renal interstitial fibrosis, upregulated glycolysis in TECs and elevated lactate levels contributed to a hypoxic and acidic microenvironment that inhibited podocyte proliferation and differentiation, thereby accelerating fibrotic remodeling (Li et al., 2018)